ArticleCell death & disease2026

USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer.

Zhipeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.